Apozema No. 51 to increase body's defenses - 15 ml

Apozema® triad globules to increase the immune system Echinacea purpurea are a homeopathic medicinal specialty from Echinacea purpurea (red coneflower) in the form of the potency chord D4/D6/D12. This means a mixture of different potencies of the same active ingredient.

The individual potency levels retain their independent effect, the spectrum of action of the potency chord is therefore broader and deeper than that of the respective individual potencies and lasts longer.

Homeopathy sees itself as a regulatory therapy for acute and chronic diseases. The areas of application are derived from the homeopathic drug pictures. This includes supportive treatment of:

• incipient influenza infections
• febrile infectious diseases
• increased susceptibility to influenza infections

The special plus

The purple coneflower (Echinacea purpurea) is native to America. The plant, with its large, purple flowers, grows to over a meter tall and blooms throughout the summer. The coneflower is known as an ancient medicinal plant and the North American Indians used it. Today, the red coneflower is used, among other things, to prevent flu infections and colds in the cold season, to increase and strengthen the body's defenses and to support respiratory infections.

composition

1 Globulum enthält:
0,0208 mg Echinacea purpurea D4; 0,0208 mg Echinacea purpurea D6; 0,0416 mg Echinacea purpurea D12.

application

The recommended dose is

Adults, adolescents and children over 10 years:
5-10 globules 3-5 times a day.
In acute cases, the dosing frequency can be increased up to 1/2 hour (maximum 8 times daily for a maximum of one day). If the symptoms improve, the frequency of application should be reduced.

Children from 3 to 10 years:
5 globules 3-5 times a day.
In acute cases, the dosing frequency can be increased up to 1/2 hour (maximum 8 times daily for a maximum of one day). If the symptoms improve, the frequency of application should be reduced.

Children under 3 years of age:
In the absence of sufficient data, use in children under 3 years of age cannot be
recommended.